Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.
about
Spotlight on fluticasone furoate/vilanterol trifenatate for the once-daily treatment of asthma: design, development and place in therapyIn Vitro Dosing Performance of the ELLIPTA® Dry Powder Inhaler Using Asthma and COPD Patient Inhalation Profiles Replicated with the Electronic Lung (eLung™).The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma.The combination of fluticasone furoate and vilanterol trifenatate in the management of asthma: clinical trial evidence and experience.Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma.Phamacology of fluticasone furoate and vilanterol trifenatate combination therapy for asthma.Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma.
P2860
Q28074802-B7F6B10B-F9EF-43D7-B07C-779975522446Q36388505-8738FB85-972B-402C-8D5F-1AA25C155E99Q36388517-B10C0797-05C7-4649-AD4A-AE6D5B4BF92CQ37200540-CBA5C7BB-CF55-4E4C-B8B8-7CFEDA9F70C0Q37436410-95E81AC4-A02E-458C-8888-3066D1DE1CF4Q38669520-6CFFD23D-67EC-4F45-ADB6-F61855F08369Q38707759-E722093E-8CC0-438E-8E08-0531A1073F01Q38947467-1F22C3D9-6986-4E84-B3F6-A918EE610FF8Q40624707-549E3231-DA45-451D-8942-F014DD748D5CQ42697426-29ACED36-9304-473E-B5E4-E19351F542A8
P2860
Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@ast
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
type
label
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@ast
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
prefLabel
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@ast
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
P2093
P2860
P50
P356
P1476
Efficacy and safety of flutica ...... s: a 24-week randomised study.
@en
P2093
Anna Ellsworth
Eric D Bateman
Loretta Jacques
Sally Stone
P2860
P2888
P356
10.1186/1471-2466-14-113
P577
2014-07-09T00:00:00Z
P5875
P6179
1052608380